Ausgabe 2/2005
Inhalt (13 Artikel)
Thirty-four-year experience of immunochemosurgery for gastric cancer in 14 033 cases
Jin-Pok Kim
Laparoscopic surgery for gastric cancer: preliminary experience
Fabio Carboni, Pasquale Lepiane, Roberto Santoro, Pietro Mancini, Riccardo Lorusso, Eugenio Santoro
Recent advances in multimodal treatment for gastric cancer: a review
Florian Lordick, J.Rüdiger Siewert
Molecular-pathological prognostic factors of gastric cancer: a review
Wataru Yasui, Naohide Oue, Phyu Phyu Aung, Shunji Matsumura, Mariko Shutoh, Hirofumi Nakayama
Current status and future prospects of chemotherapy for metastatic gastric cancer: a review
Atsushi Ohtsu
Minimally invasive surgery for gastric cancer — toward a confluence of two major streams: a review
Yuko Kitagawa, Seigo Kitano, Tetsuro Kubota, Koichiro Kumai, Yoshihide Otani, Yoshiro Saikawa, Masashi Yoshida, Masaki Kitajima
Long-term outcome of S-1 and cisplatin combination therapy in patients with advanced or recurrent gastric cancer
Yoshihisa Sakaguchi, Akira Kabashima, Keishi Okita, Yasutomo Ojima, Shinji Yamamura, Takashi Nishizaki, Hideya Tashiro, Toshimitsu Matsusaka
Gastric adenocarcinoma among Hmong in California, USA, 1988–2000
Richard C. Yang, Paul K. Mills, Deborah G. Riordan
Clinical significance of interleukin-6 (IL-6) in the spread of gastric cancer: role of IL-6 as a prognostic factor
Tatsuto Ashizawa, Ryosuke Okada, Yoshiaki Suzuki, Makoto Takagi, Tatsuyuki Yamazaki, Tetsuo Sumi, Toshiaki Aoki, Shinobu Ohnuma, Tatsuya Aoki